PEPTIDE-T FROM HUMAN-IMMUNODEFICIENCY-VIRUS DOES NOT INTERACT WITH VIP RECEPTOR-EFFECTOR SYSTEM IN IMMUNOCOMPETENT CELLS OF RAT AND MOUSE

被引：1
|
作者：
POZO, D [1 ]
SEGURA, JJ [1 ]
GUERRERO, JM [1 ]
CALVO, JR [1 ]
机构：
[1] UNIV SEVILLE,SCH MED,DEPT MED BIOCHEM & MOLEC BIOL,E-41009 SEVILLE,SPAIN
来源：
BIOSCIENCE REPORTS | 1994年 / 14卷 / 05期
关键词：
VIP; IMMUNOCOMPETENT CELLS; HIV; PEPTIDE T;
D O I：
10.1007/BF01209730
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Human immunodeficiency virus (HIV) infection is initiated by attachment of the virus to specific target cells. An octapeptide sequence contained within the envelope of HIV, peptide T, mediates the viral binding. Since there is an appreciable structural similarity between peptide T and an eight amino acid sequence of VIP, it is interesting to investigate the interaction of peptide T with the VIP receptor-effector system of immunocompetent cells from both rat and mouse. In this paper, we show the lack of interaction between peptide T and VIP receptor-effector system in peripheral blood lymphocytes, spleen lymphocytes and macrophages of rat and in macrophages of mouse. These results do not support the hypothesis that HIV through peptide T may interact with the VIP receptor-effector system present in immunocompetent cells.
引用
收藏
页码：251 / 257
页数：7
相关论文
共 46 条
  • [1] Thymosin alpha 1 interacts with the VIP receptor-effector system in rat and mouse immunocompetent cells
    Pozo, D
    Guerrero, JM
    Segura, JJ
    Calvo, JR
    IMMUNOPHARMACOLOGY, 1996, 34 (2-3): : 113 - 123
  • [2] PEPTIDE-T FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE DOES NOT INTERACT WITH HEPATIC, INTESTINAL AND COLONIC VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTORS
    NGUYEN, TD
    PEPTIDES, 1988, 9 (02) : 425 - 428
  • [3] Postnatal development of vasoactive intestinal peptide receptor-effector system in rat immunocompetent cells
    Pozo, D
    Guerrero, JM
    Calvo, JR
    VIP, PACAP, GLUCAGON, AND RELATED PEPTIDES, 2000, 921 : 357 - 361
  • [4] Functional and molecular characterization of VIP receptor-effector system in rat developing immunocompetent cells: G protein involvement
    Pozo, D
    Guerrero, JM
    Calvo, JR
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 103 (01) : 41 - 50
  • [5] Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages
    Pozo, D
    Montilla, ML
    Guerrero, JM
    Calvo, JR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 321 (03) : 379 - 386
  • [6] THYMOSIN ALPHA-1 - AMINO-ACID HOMOLOGY WITH PEPTIDE-T FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE
    NGUYEN, TD
    SCHEVING, LA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (02) : 884 - 887
  • [7] THE VASOACTIVE INTESTINAL PEPTIDE RECEPTOR-EFFECTOR SYSTEM IS DEVELOPMENTALLY REGULATED IN RAT JEJUNO-ILEAL EPITHELIAL-CELLS
    FERNANDEZMORENO, MD
    DIAZJUAREZ, JL
    FERNANDEZGONZALEZ, MA
    SANCHEZFRANCO, F
    PRIETO, JC
    BIOCHEMISTRY INTERNATIONAL, 1988, 16 (02): : 331 - 337
  • [8] Effects of chronic ethanol ingestion on the vasoactive intestinal peptide receptor-effector system from rat seminal vesicle membranes
    Juarranz, MG
    Marinero, MJ
    Bodega, G
    Prieto, JC
    Guijarro, LG
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1999, 23 (02) : 318 - 323
  • [9] ILEAL VASOACTIVE-INTESTINAL-PEPTIDE (VIP) LEVELS AND VIP RECEPTOR EFFECTOR SYSTEM IN ILEAL EPITHELIAL-CELLS AFTER COLECTOMY IN THE RAT
    FERNANDEZMORENO, MD
    FERNANDEZGONZALEZ, MA
    ARILLA, E
    LORENZO, MJ
    PRIETO, JC
    BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1987, 38 (02): : 213 - 218
  • [10] HIGH NUMBERS OF T-CELLS IN GINGIVA FROM PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    ODDEN, K
    SCHENCK, K
    HURLEN, B
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1995, 24 (09) : 413 - 419
12345